Tetraphase Pharmaceuticals, Inc. (TTPH) Loss Form

See If You Qualify For Monetary Reward

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.

Submit Transaction Detail Now (Optional)

- OR -

    This submission does not create an attorney-client relationship. We will keep you up to date with this investigation, and should this investigation evolve, we will contact you to discuss whether to establish an attorney client relationship at no cost to you.

    FAX: 212-363-7171

    Levi & Korsinsky announces the commencement of a class action in the United States District Court for the Southern District of New York on behalf of Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) shareholders who purchased shares pursuant to the July 2017 secondary public offering and/or between March 8, 2017 and February 13, 2018.

    If you suffered a loss in Tetraphase Pharmaceuticals you have until September 25, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.